Research on infections caused by bacteria and how to fight them. Covers antibiotic resistance, biofilms, congenital syphilis, Lyme disease, and precise treatments.
Liangfang Zhang's invention uses human cell membranes to cloak nanoparticles, making them deliver drugs and remove toxins more effectively. The approach has shown promise against bacterial toxins, including MRSA, and may potentially treat diseases without conventional drugs.
A blood test that compares two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever. The test showed a high sensitivity and specificity, and could potentially improve treatment and reduce unnecessary antibiotic use.
Researchers have identified a way to strengthen bladder cells' ability to eliminate hidden bacteria, reducing recurrent UTIs. OM-89 increases lysosomal acidification and enzyme activity, allowing antibiotics to reach and kill bacteria more effectively.
The guideline establishes a framework for personalized phage therapy, including standardized procedures for selecting and testing phages, infrastructure development, and quality control. Clinical research indicates a favorable safety profile, but efficacy has yet to be fully demonstrated.
Researchers found Campylobacter, Salmonella, Shigella, and Pseudomonas aeruginosa bacteria in 13%, 10%, 3%, and 12% of tanks, respectively, with elevated metal levels detected in metal tanks and poorly maintained systems. Regular maintenance and proper handling of rainwater systems are crucial to ensure water quality and public health.
Researchers at Tokyo Metropolitan University identified how deadly E. coli bacteria spread using a chain-like adherence pattern under flow, and discovered a new gene family mediating this process. This discovery provides new insights into infection mechanisms and potential treatments for LEE-negative strains.
Researchers at the University of Osaka have identified a previously unknown mechanism that allows the bacterium Streptococcus pneumoniae to export the antibiotic fosfomycin. The discovery provides new clues to drug resistance and could lead to the development of more effective treatments for bacterial infections.
Denmark's unique approach to prenatal care, including universal syphilis screening, has led to zero congenital syphilis cases since 2016. The study found nearly 100% screening coverage and a stable trend in syphilis infections, but no increase in congenital syphilis cases, indicating a well-functioning healthcare system.
Researchers have identified an enzyme from cow gut that can break down bacterial biofilm components, making them more vulnerable to antibiotics. The enzyme, CRhAB, was found to be effective against two notorious pathogen groups, including Acinetobacter baumannii, which poses a significant threat in healthcare settings.
UCF researcher Mollie Jewett aims to 'starve' Borrelia burgdorferi of nutrients to prevent Lyme disease spread. Her team is focused on targeting the bacteria's ability to consume riboflavin, a key nutrient for its survival.
Researchers have discovered a previously overlooked group of bladder nerves that help detect urinary tract infections and trigger the body's response to clear them. These nerves, located close to the bladder lining, act as an early warning system that springs into action during a UTI, helping to reduce severity and spread of infection.
A cohort study identified risk factors for bacterial infection after firearm injury and found an association between bacterial infection and increased mortality among US adults. The study assesses the impact of firearm injuries on health outcomes in this population.
A novel treatment approach combining phage therapy and fecal microbiota transplantation has shown promise in treating recurring urinary tract infections. The study, published in Nature Microbiology, found that the treatment reduced UTI episodes and improved quality of life for patients.
Researchers are studying foul-smelling substances to understand what attracts the New World screwworm, a flesh-eating parasite, to its favorite meal - open wounds. The goal is to develop better lures for trapping this serious threat to the livestock industry.
Researchers at the University of Washington School of Medicine discovered that environmental bacteria can acquire and transfer antibiotic resistance genes to disease-causing bacteria in human lungs. This mechanism, previously unknown, could lead to rapid development of extreme antibiotic resistance. The study highlights the potential f...
Researchers at St. Jude Children's Research Hospital discovered an RNA-based survival strategy that enables bacteria to tolerate antibiotics. The findings provide new insights into how persistent infections develop and could inform strategies to improve antibiotic effectiveness. Antibiotic tolerance allows bacteria to survive treatment...
Researchers have developed a new approach to combat superbugs by partnering existing antibiotics with molecular compounds called adjuvants. Using this method, they successfully restored the activity of vancomycin against drug-resistant E. faecium, a potentially life-threatening infection.
Scientists have created a novel antibiotic that targets starved bacteria by blocking energy-coupling factor transporters. The breakthrough offers hope for tackling drug-resistant infections, with promising results in mouse models and no resistant bacterial variants emerging.
The DZIF-supported project PROTON aims to develop innovative agents against Staphylococcus aureus, a bacterial pathogen responsible for severe lung infections. The active agent, a pathoblocker, targets the toxin that destroys lung tissue and immune cells, reducing antibiotic resistance.
Researchers have discovered a novel agrochemical target, C31, that inhibits Xanthomonas bacterial leaf blight by targeting the RNA polymerase alpha subunit, RpoA. This study demonstrates the potential of liquid-liquid phase separation as an innovative approach to developing new plant disease control strategies.
Researchers at UT San Antonio develop non-toxic biologic to prevent Lyme disease transmission. The treatment targets small mammals and birds, reducing bacterial loads in ticks, and may soon be available for residential use.
A new study by Flinders University reveals that targeting specific pain receptors in the bladder can reduce debilitating effects of cystitis. The research suggests that activating certain cannabinoid receptors could provide relief from bladder pain and urinary urgency associated with interstitial cystitis/bladder pain syndrome (IC/BPS).
Researchers identified five immunomodulatory proteins in Borrelia recurrentis that prevent activation of the human complement system, allowing the pathogen to survive in the human body. These Chi proteins also convert plasminogen into active plasmin, giving Borrelia recurrentis a significant advantage in spreading after infection.
Researchers have developed an alternative infection model using wax moth larvae to study bacterial pathogens, enabling efficient and ethically acceptable high-throughput testing. The model allows for broad screening of bacterial variants or potential new active compounds in a living organism.
Dr. Renee Fleeman's research found a bioengineered peptide weakens the defenses of Klebsiella pneumoniae bacteria and destroys it, potentially treating patients with severe infections. The findings show the peptide can kill biofilm-embedded bacteria in animal models.
A nationally representative survey of empaneled adults found that most Americans understand how STIs spread, but there are significant gaps in public knowledge about which infections can be prevented through vaccination. The survey also revealed strong awareness of common transmission pathways and some basic facts about STIs.
Researchers found that treating woodland trails with woodchips and insecticide significantly reduced the density of blacklegged ticks, a primary vector of Lyme disease. The study demonstrated that both deltamethrin-treated and untreated woodchip interventions can effectively reduce tick populations in recreational contexts.
Researchers engineer bacterial vesicles into multifunctional tools that can kill pathogens, boost vaccines, and deliver targeted therapies. Engineered BEVs address key limitations of existing therapies, including improving vaccine responses and antibiotic delivery.
A new study from Weill Cornell Medicine found that the protein caspase-5 boosts cell growth in the gut lining by amplifying Wnt signaling. This balance is crucial for maintaining a healthy intestinal lining, replacing injured cells with new ones, and preventing diseases like colorectal cancer and inflammatory bowel disease.
A study from Tulane University found that long-term, untreated syphilis increases the risk of serious cardiovascular issues, including stroke, heart attack, and aortic aneurysm. Adults with syphilis were more likely to develop these problems than similar patients without the infection.
A pre-Columbian Bolivian mummy has been found to harbor the ancient Streptococcus pyogenes bacterium, a pathogen responsible for scarlet fever. The genome of this centuries-old bacterium was reconstructed from its DNA, revealing genetic variants that may no longer exist today.
Researchers found that Vibrio cholerae can efficiently acquire new sedentary chromosomal integron (SCI) gene cassettes from extracellular DNA. This process allows the bacteria to diversify its antiviral defenses and potentially expand its protection against viruses in different environments.
Scientists have discovered that a fast-rising strep bacterium comes in more forms than expected, with distinct variants linked to specific types of infections. The study provides critical genetic data to improve diagnosis, infection control, and future vaccine planning for this growing bacterial threat.
A study from the Ragon Institute reveals how a live bacterial therapy works to prevent recurrent bacterial vaginosis (BV) and why it works better for some women than others. The therapy, LACTIN-V, was found to successfully colonize the beneficial bacterium Lactobacillus crispatus in 30% of women, leading to improved vaginal health.
Researchers developed an AI tool called PathogenFinder2 that can detect harmful bacteria before they infect humans. The tool uses protein language models and has been shown to significantly improve the detection of bacterial threats.
Using azithromycin within one day triggers antibiotic resistance in the respiratory tract, according to a study published in Nature Microbiology. The researchers followed hospitalized COVID-19 patients and found that azithromycin changed the mix of microbes in the upper airway, leading to persistent changes for more than a week.
A study found that babies who develop severe E. coli infections lack sufficient germ-fighting antibodies, which mothers transfer to their babies. The research suggests that these antibodies protect against infection, and developing a screening test to identify high-risk newborns could prevent severe illnesses.
A new study discovered that a multifaceted infection prevention and control intervention successfully disrupted a large and long-running bacterial outbreak of Klebsiella pneumoniae in a Zambian neonatal intensive care unit. The study found that low-cost measures, including IPC training, enhanced cleaning, and hand hygiene, reduced neon...
A Rapid Outbreak Assessment published by ECDC and EFSA concludes that the likelihood of exposure to contaminated infant formula is low due to ongoing recalls. Most affected children experience mild symptoms, but infants under six months are more vulnerable to dehydration and electrolyte disturbances.
A new joint report from EFSA and ECDC highlights the ongoing threat of antimicrobial resistance in common foodborne bacteria such as Salmonella and Campylobacter. Despite some encouraging signals, progress has been limited, and continued action is essential to slow the emergence and spread of antimicrobial-resistant bacteria.
A Dartmouth study found that plasmids can form tight clusters within bacterial communities, making them resistant to antibiotics and clinical treatments. This phenomenon introduces a new avenue for bacterial infections to become more difficult to treat.
Bacterial infections are common and severe complications in patients with liver cirrhosis, with a global prevalence of 35.1% reported. The most common infection sites were the gastrointestinal tract, ascites fluid, and urinary tract, with gram-negative organisms more frequent than gram-positive organisms.
Researchers at the University of Arizona have developed a copper-based compound that can kill MRSA bacteria by disguising itself as iron. The compound, BMDC, works by delivering a toxic dose of copper to bacterial colonies, making it an effective treatment against drug-resistant infections.
Researchers at NTU Singapore have found that a common bacterium produces reactive oxygen species that impairs wound healing. Neutralizing this process with an antioxidant enzyme restores skin cells' ability to migrate and heal, offering a potential solution to tackle antibiotic-resistant strains.
A comprehensive genomic characterisation of E. coli strains isolated from diabetic foot ulcers reveals high diversity and antibiotic resistance. The study provides valuable insights into the specific pathogens involved in diabetic foot disease and suggests potential targets for improved treatment strategies.
Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.
A high-protein diet rich in casein and wheat gluten can significantly reduce the amount of cholera bacteria able to infect the gut. The study found that these dietary components can suppress a key structure on the surface of cholera bacteria, making it difficult for the pathogen to colonize and cause harm.
A new study reveals that farmers in the Northeast are facing a growing threat of tick-borne diseases, which can be devastating to their livelihoods. The research found that farmers often experience multiple tick bites per month, with some contracting serious illnesses like Lyme carditis.
A systematic review and meta-analysis found that ceftazidime-avibactam is more effective than standard antibiotic therapy in managing drug-resistant Klebsiella pneumoniae infections. The treatment also showed a lower rate of adverse reactions and mortality. The results suggest that ceftazidime-avibactam is a more favorable choice for c...
A study published in the International Journal of Infectious Diseases found that delafloxacin inhibits Legionella replication more effectively than levofloxacin. The antibiotic demonstrates promising intracellular activity, which could support further clinical investigation as a potential treatment for Legionnaires' disease.
Public Health Alerts provide concise, data-driven information on disease outbreaks and urgent health events. The new series, launched by NEJM Evidence and CIDRAP, offers expert-reviewed reports to support public health evidence-based care.
Researchers at TUM developed a new method that allows for direct analysis of urine to determine antibiotic resistance in urinary tract infections. The test reduces the time to result by up to 24 hours compared to conventional testing, enabling healthcare providers to prescribe more targeted treatments.
A team of researchers has identified two proteins critical to the destruction of red blood cells by the Oroya fever pathogen. This discovery paves the way for a potential novel therapy against this deadly neglected tropical disease.
A new study from the University of Gothenburg has found that high teenage BMI and poor physical fitness are associated with a higher risk of developing severe bacterial infections in adulthood. The study, which followed over 44,000 men for three decades, shows that even at high normal weight, individuals are already at increased risk.
A SickKids-led study reveals how bile acids can bind to block C. diff's most dangerous toxin, leading to the development of a new compound that neutralizes the toxin directly in the gut. This approach preserves gut health and targets the toxin with precision, offering hope for safer treatments.
A study suggests that volcanic activity around 1345 CE led to crop failures and famine in southern Europe, prompting Italian city states to import grain shipments from the Black Sea region contaminated with Yersinia pestis. This grain trade may have exacerbated the spread of the plague across Europe.
Researchers from North Carolina State University have confirmed a new species of Rickettsia bacteria found in dogs, associated with symptoms similar to those of Rocky Mountain spotted fever. The new species, Rickettsia finnyi, has been cultured and sequenced, and its genome revealed a unique circular chromosome.
Researchers have developed a new molecular test to identify Lyme disease earlier and more accurately than traditional methods. The test can detect as few as five bacterial cells and has an estimated sensitivity of 90.9%, making it a potential new avenue for testing Lyme disease.
Researchers have discovered that manganese is both an armor and a weakness for the Lyme disease bacterium, Borrelia burgdorferi. Exploiting this vulnerability could lead to new therapeutic strategies for treating the disease.
The Phase 3 study demonstrated the safety and non-inferiority of EuTYPH-C Inj.® Multi-dose compared to a World Health Organization (WHO) prequalified comparator TCV, Typbar TCV®. The vaccine was shown to be well-tolerated across all age groups with no serious adverse events.